Literature DB >> 2417315

Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants.

K Marsh, R J Howard.   

Abstract

Red blood cells that are infected with the malaria parasite Plasmodium falciparum express new antigens on their surface. In a study of these antigens in the erythrocytes of naturally infected children in the Gambia, an antibody-mediated agglutination assay revealed an extreme degree of antigenic diversity. Serum samples from each of ten children in the convalescent stage of malaria infection reacted with infected cells from the same child but generally not with infected cells from the other children. The Gambian children's erythrocytes also expressed shared determinants: sera from Gambian adults often reacted with the surface of infected cells from all of the children and were shown by adsorption and elution experiments to contain antibodies that recognized several isolates. Conserved determinants exposed on infected erythrocytes may be important for development of antimalarial immunity either naturally or through vaccination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417315     DOI: 10.1126/science.2417315

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  114 in total

1.  Immune characterization of Plasmodium falciparum parasites with a shared genetic signature in a region of decreasing transmission.

Authors:  Amy K Bei; Ababacar Diouf; Kazutoyo Miura; Daniel B Larremore; Ulf Ribacke; Gregory Tullo; Eli L Moss; Daniel E Neafsey; Rachel F Daniels; Amir E Zeituni; Iguosadolo Nosamiefan; Sarah K Volkman; Ambroise D Ahouidi; Daouda Ndiaye; Tandakha Dieye; Souleymane Mboup; Caroline O Buckee; Carole A Long; Dyann F Wirth
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Specificity and cross-reactivity of Plasmodium falciparum variant surface antigen-specific antibody responses.

Authors:  Lars Hviid; Trine Staalsoe; Morten A Nielsen; Thor G Theander
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks.

Authors:  Gerardo Cabrera; Clarisse Yone; Anne E Tebo; Jan van Aaken; Bertrand Lell; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 4.  Understanding naturally acquired immunity to Plasmodium falciparum malaria.

Authors:  D J Roberts
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

5.  Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population.

Authors:  D J Conway; B M Greenwood; J S McBride
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens.

Authors:  Rosette Megnekou; Trine Staalsoe; Diane W Taylor; Rose Leke; Lars Hviid
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 7.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 8.  Structure and possible function of Plasmodium falciparum proteins exported to the erythrocyte membrane.

Authors:  B Knapp; E Hundt; K R Lingelbach
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

9.  Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.

Authors:  Trine Staalsoe; Caroline E Shulman; Edgar K Dorman; Ken Kawuondo; Kevin Marsh; Lars Hviid
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 10.  Young lives lost as B cells falter: what we are learning about antibody responses in malaria.

Authors:  Silvia Portugal; Susan K Pierce; Peter D Crompton
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.